USPTO serial 88153684
IMPROVING LIVES WITH PRECISION DIAGNOSTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 12, 2022
- Examiner
- KETCHUM, BRENDAN J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with IMPROVING LIVES WITH PRECISION DIAGNOSTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sarah W. Matthews
Sarah W. Matthews Dentons Durham Jones Pinegar3301 N Thanksgiving Way, Suite 400Lehi, UT 84043United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for scientific and research use, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in polymerase chain reaction, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in polymerase chain reaction, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for research, clinical research, and laboratory research use | ACTIVE | Oct 10, 2018 |
| 005 | Assays for the treatment or diagnosis of disease; medical diagnostic reagents, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in polymerase chain reaction, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic kits comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in polymerase chain reaction, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatment, monitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for testing of bodily fluids | ACTIVE | Oct 10, 2018 |
| 042 | DNA analysis services for scientific research purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays; providing medical testing and consultation services for both clinical research and research applications | ACTIVE | Oct 10, 2018 |
| 044 | DNA screening for medical purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays; providing information services regarding the diagnosis, monitoring and options in the treatment of leukemia; providing medical testing and consultation services for clinical applications | ACTIVE | Oct 10, 2018 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Invivoscribe, Inc.
- Other trademarks owned by Invivoscribe, Inc.
- Other trademarks owned by Invivoscribe, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named IMPROVING LIVES WITH PRECISION DIAGNOSTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 10, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 10, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 10, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 12, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 12, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 7, 2022 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jun 6, 2022 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 16, 2022 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 13, 2022 | IUAF | USE AMENDMENT FILED | — |
| May 13, 2022 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Nov 23, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 20, 2021 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Nov 20, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 15, 2021 | EXT5 | SOU EXTENSION 5 FILED | — |
| Nov 15, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 22, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 20, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 20, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 20, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 18, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 16, 2020 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 16, 2020 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 16, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 22, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 20, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 20, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 20, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 23, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 21, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 21, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 21, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 21, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 26, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 26, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 6, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 15, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jan 30, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 30, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 30, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 30, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 30, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 23, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 24, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 16, 2018 | NWAP | NEW APPLICATION ENTERED | — |